Supplements– category –
-
Oral GLP-1 Orforglipron Approved by FDA — Not the Same as Mounjaro: Efficacy, Side Effects, and What It Means
April 1, 2026: U.S. FDA approves orforglipron, the first oral GLP-1 obesity drug with no water or food restrictions. ATTAIN-1 trial: -12.4% weight loss. Hidden Japan story: compound licensed from Chugai for $50M in 2018. -
Omega-3 Supplements Linked to Faster Cognitive Decline? Decoding the May 2026 Bombshell Study
In May 2026, the Journal of Prevention of Alzheimer's Disease published ADNI cohort data on 819 older adults: omega-3 supplement users showed faster cognitive decline on MMSE, ADAS-Cog13, and CDR-SB. Correlated with reduced brain glucose metabolism, independent of APOE ε4. Why this matters and how to reconcile with DO-HEALTH 2025. -
[Features] NMN Just Got EU Safety Approval — What It Means (and What It Doesn’t)
EFSA cleared NMN at up to 300 mg/day as safe in May 2026. That is not the same as proving it works. An independent, ad-free audit of the human evidence at Levels 1-4. -
All Supplements — A Complete List of Supplements Backed by Scientific Research
[Category] Supplements — A Complete List of Supplements Verified by Scientific Research About this category Supplements are not meant to replace meals; rather, they are intended to be used as a supplement to address specific nutritional ...
1